Oppenheimer raises Blackstone stock price target on earnings results By Investing.com

Oppenheimer raised Blackstone’s price target to $156 from $154 and reiterated Outperform, saying the earnings report was fundamentally in line with expectations and that the 5.7% post-earnings sell-off was not justified. Blackstone also reported Q1 2026 EPS of $1.36 versus $1.34 expected and revenue of $3.62 billion versus $3.41 billion expected. The note highlights AI/software exposure concerns affecting trading more than the underlying results.

Analysis

BX is behaving less like a single-name earnings story and more like a proxy for the market’s tolerance for duration and multiple risk. The key second-order dynamic is that public REITs, software, and carry-sensitive alternatives platforms tend to get sold together when investors de-risk “AI exposure” broadly, even if the underlying cash-flow mechanics differ materially. That creates an opportunity: any continuation of this tape should favor firms with fee-related earnings resilience over names whose valuation still embeds aggressive terminal growth assumptions.

The near-term catalyst is sentiment normalization, not fundamental inflection. If the market was punishing BX for perceived AI/software adjacency rather than economics, the reversal can happen quickly over 1-3 sessions once the broader factor basket stabilizes; but the medium-term risk is that investors keep compressing multiples on every sign of cyclicality in alternatives fundraising. The more important tell will be whether higher-rate expectations or weaker M&A/exit conditions start to pressure deployment pace and incentive fee visibility over the next 1-2 quarters.

The contrarian view is that the market may be underestimating how much of BX’s equity story is now driven by private-market liquidity, not just headline AUM. A second-order benefit of a stressed public tech tape is that it can widen the gap between public and private marks, making secondaries and opportunistic funds more relevant over time. If that mechanism holds, yesterday’s selloff was likely too large relative to the actual earnings delta.

For trading, the cleanest expression is to buy BX on weakness only if it is being dragged by broad factor deleveraging, not if credit spreads are widening in tandem. Risk/reward improves if paired against a more duration-sensitive software or asset-manager basket that has similar sentiment beta but weaker cash-flow durability. The downside case is a sustained rotation out of alternatives if IPO/M&A markets stay shut through the next quarter, which would justify trimming quickly on any failed rebound.

Key Decisions for Investors

• Long BX on a 1-3 day dislocation only if it reclaims prior support after the initial post-earnings de-risking; target a 6-10% rebound, stop if it fails to recover within 48 hours.
• Pair trade: long BX / short IGV for 2-6 weeks to isolate the overreaction to 'AI/software exposure' headlines; risk is a sharp broad tech rebound, so keep sizing modest.
• Add BX only on evidence that fundraising or secondaries momentum remains intact over the next quarter; that is the cleanest fundamental catalyst to re-rate fee durability.
• Avoid chasing a standalone long if rates move higher or credit spreads widen; those two variables would pressure private-market exits and likely keep the multiple capped.
• If owning BX already, use call overwrites or trim into strength above the revised target zone to monetize sentiment normalization while leaving room for a longer-term secondaries thesis.